Quantum-Si, Inc.

As of September 11, 2025, Quantum-Si, Inc. is in a mildly bearish trend despite recent outperformance against the S&P 500, with weekly indicators showing bearish signals while longer-term performance remains significantly negative.

As of February 29, 2024, Quantum-Si, Inc. is classified as "risky" due to overvaluation based on key financial metrics, despite a recent strong weekly return of 27.50%, it has declined 43.33% year-to-date, highlighting its volatility and poor long-term performance.

As of February 29, 2024, Quantum-Si, Inc. is rated as "risky" and overvalued, with key financial metrics indicating poor performance, including a Price to Book Value of 1.29, an EV to Sales ratio of 25.74, a ROE of -39.67%, and a year-to-date stock decline of 38.89% compared to the S&P 500's gain of 2.44%.

As of June 18, 2025, the trend is bullish with moderate strength from daily moving averages and weekly MACD, but caution is advised due to a bearish monthly RSI and mixed signals from other indicators.

Quantum-Si, Inc. is a blank check company focused on acquiring and developing businesses in the life sciences sector, specifically within the Software Products industry. As of March 2025, it reported net sales of $1 million and a net loss of $19 million, with a market cap of $308.28 million.

As of Jun 18, Quantum-Si, Inc. has a market capitalization of 308.28 million and reported net sales of 3.44 million with a net profit of -100.72 million over the last four quarters. The balance sheet shows shareholder's funds of 215.42 million and total assets of 247.87 million.